Invetx
Boston
About Invetx
Invetx is a veterinary therapeutics company that develops protein-based therapeutics for animal health. Invetx's network includes animal and human health experts, veterinary scientists, and clinicians. The company's vision is of a global animal health industry that fully leverages biopharma technologies to deliver dramatically improved health outcomes for pets and farm animal populations.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $85.8M
- Funding stage: M&A
- Last round: Series B (May 2022)
- Website: invetx.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Veterinary
Social Profiles
Canonical: https://fsome.com/organization/invetx-16387 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.